News Results

There are 722,957 News Results

Sep 29, 2025
American Rebel Holdings, Inc. (NASDAQ: AREB) and TSR Nitro Celebrate the American Rebel Beer Dodge Hellcat Victory at NHRA Midwest Nationals—Matt Hagan Wins Big in St. Louis
Matt Hagan Powers American Rebel to Victory at NHRA Midwest Nationals—American Rebel Beer Dodge Hellcat Claims First Win of 2025
Oct 1, 2025
October is National Liver Awareness and Liver Cancer Month, Do You Know Your Liver Health?
Take ALF's liver health quiz, try a liver healthy recipe, advocate for liver health, and participate in free educational and community events all month long!
Oct 2, 2025
Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson's Disease and Movement Disorders® 2025
-- Details of the Phase 3 MASCOT trial investigating amlenetug for the treatment of patients with Multiple System Atrophy (MSA) will be presented at the International Congress of Parkinson's Disease...
Oct 2, 2025
American Rebel Holdings, Inc. (NASDAQ: AREB) Planned Strategic 1-for-20 Reverse Stock Split with Round Lot Shareholder Protection to begin trading on a post-split adjusted basis on October 3, 2025
1-for-20 Reverse Split with Round Lot Shareholder Protections to Support Ongoing Nasdaq Compliance Efforts, Strengthen Liquidity, and Facilitate Broader Retail Brokerage Deposits
Jun 2, 2017
Further Study of Combination of Eisai's Lenvatinib and Merck's Pembrolizumab in Previously Treated Patients with Metastatic Endometrial Cancer Supported by Interim Analysis of Ongoing Phase 1b/2 Trial
WOODCLIFF LAKE, N.J., June 3, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the first evaluable cohort of Study 111, a Phase 1b/2 study investigating lenvatinib (marketed as...
Jun 6, 2017
Equity Strategies Snag All Top 20 Spots on eVestment Global Screening List; UK Users Globally Focused
ATLANTA, June 7, 2017 /PRNewswire/ -- All 20 of the most popular investment products viewed in May by institutional investment professionals using eVestment were equity focused in May 2017, according...
Jul 9, 2017
Global Next Generation Sequencers - Clinical Diagnostics
NEW YORK, July 10, 2017 /PRNewswire/ --
Jul 9, 2017
Global Acute Myeloid Leukemia (AML) Therapeutics - Pharmaceuticals
NEW YORK, July 10, 2017 /PRNewswire/ --
Jul 24, 2017
Eisai Submits Supplemental New Drug Application to FDA for Lenvatinib in First-Line Hepatocellular Carcinoma
WOODCLIFF LAKE, N.J., July 25, 2017 /PRNewswire/ -- Eisai Inc. today announced it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the...
Sep 9, 2017
Combination of Lenvatinib and Pembrolizumab Results in Notable Response Rates for Patients with Advanced Renal Cell Carcinoma Based on Interim Analysis of Ongoing Phase 1b/2 Trial
WOODCLIFF LAKE, N.J., Sept. 10, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the advanced renal cell carcinoma (RCC) cohort of Study 111, a Phase 1b/2 study investigating...
72296

Pages

1

Stories of the day

Sep 30, 2025
EOS unveils Atlas Space Control capability at IAC 2025
Sep 30, 2025
Royal Thai Air Force adds two Airbus H225 helicopters
Oct 1, 2025
MBDA signed production contract for TESEO MK2/E anti-ship missile for the...
Oct 1, 2025
Lockheed Martin Begins Critical Testing on Aegis System Equipped Vessel Antennas